bd - Search News

BD bids farewell to its diagnostic, bioscience divisions with company split

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses—as the company near | The “New BD,

Business Insider · 1d

Becton Dickinson to Split from Bioscience and Diagnostic Solutions Arms

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic solutions arms to become

Reuters · 16h

Becton looks to separate biosciences and diagnostic solutions after upbeat quarterly results

Becton Dickinson beat expectations for first-quarter results and said its board has authorized a plan to separate its biosciences and diagnostic solutions unit on Wednesday, as the medical device maker aims to focus on its core business.

Modern Healthcare · 13h

Becton Dickinson to break off biosciences, diagnostic solutions

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

The Wall Street Journal on MSN · 1d

Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and allow the company to invest more in innovation and margin growth.

BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of ...

Zacks.com on MSN14h

BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin Up

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...

15hon MSN

BD stock slides amid earnings report, business split update

Becton Dickinson (NYSE:BDX) stock was down 3% in morning trading Thursday, the day after the company released its fiscal Q1 earnings report and confirmed it was splitting the company into two separate ...

MassDevice18h

BD announces intent to sell Life Sciences business, beats Street in Q1

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences business.

16h

Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

BD sees FY25 adjusted EPS $14.30-$14.60 vs. previous view $14.25-$14.60

Consensus is $14.35. Sees FY25 revenue $21.7B-$21.9B vs. previous view $21.9B-$22.1B, consensus $21.93B.Maximize Your Portfolio with Data ...

MassDevice3d

Activist investors reportedly push BD to sell Life Sciences biz

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

16h

Becton, Dickinson and Company (BDX) Q1 2025 Earnings Call Transcript

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Bdcnetwork.com13h

Top 50 Laboratory Construction Firms for 2024

Whiting-Turner Contracting, Suffolk Construction, Skanska USA, STO Building Group, Truebeck Construction, and Hensel Phelps ...

Soap Central on MSN2d

Ye releases first YZY Womenswear BD-01 Bodysuit: All you need to know

Kanye West, also known as ‘Ye,’ is starting his women’s fashion venture by launching the YZY Womenswear line. The American ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics